Note 2 — Supplementary Balance Sheet Information

Cash, Cash Equivalents and Restricted Cash

The Company maintains accounts outside the United States denominated in currencies other than the U.S. dollar. All amounts in domestic accounts are denominated in U.S. dollars. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same such amounts shown in the Consolidated Statements of Cash Flows.

Cash, cash equivalents and restricted cash balances are summarized as follows:



(in thousands)	March 31, 2019		December 31, 2018
Cash and cash equivalents in domestic accounts	$	434,130	405,535
Cash and cash equivalents in foreign accounts		60,516	65,621
Total cash and cash equivalents		494,646	471,156
Restricted cash included in other long-term assets		2,165	3,123
Total cash, cash equivalents and restricted cash shown in the statements of cash flows	$	496,811	474,279

Restricted cash included in other assets in the Consolidated Balance Sheets represents immaterial amounts required across the Company’s segments for operational purposes.

Prepaid Expenses and Other Current Assets

Significant components of prepaid expenses and other current assets are summarized as follows:



(in thousands)	March 31, 2019		December 31, 2018
Prepaid expenses	$	63,088	48,058
Income taxes receivable		26,782	19,362
R&D state tax credit		21,593	26,541
Supplies inventory		20,074	18,089
Other		68,692	76,305
Total	$	200,229	188,355

Other Current Liabilities

Significant components of other current liabilities are summarized as follows:



(in thousands)	March 31, 2019		December 31, 2018
Accrued card brand fees	$	62,637	55,991
Accrued interest		53,960	22,191
Accrued third-party commissions		52,187	46,977
Accrued expenses		29,705	25,178
Dividends payable		23,736	24,645
Other		93,553	93,168
Total	$	315,778	268,150

Accumulated Other Comprehensive Loss (AOCL)

The income tax effects allocated to and the cumulative balance of accumulated other comprehensive income (“AOCI”) (loss) attributable to TSYS shareholders are as follows:


(in thousands)	Foreign Currency Translation Adjustments		Gain on Available-For-Sale Securities		Change in Postretirement Healthcare Plans		Total Accumulated Other Comprehensive Loss, Net of Tax
Balance as of December 31, 2018	$	(63,186)		5,052		(2,089)	$	(60,223)
Reclassification from adoption of ASU No. 2016-01 (Note 1)		-		(5,052)		-		(5,052)
Balance after reclassification (a)		(63,186)		-		(2,089)		(65,275)
Pretax amount		11,418		-		(231)		11,187
Tax effect		992		-		(52)		940
Net-of-tax amount (b)		10,426		-		(179)		10,247
Balance as of March 31, 2019 (a)+(b)	$	(52,760)		-		(2,268)	$	(55,028)